- Home
- POAI vs ADTX Comparison
POAI vs ADTX Comparison
Compare POAI & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- ADTX
- Stock Information
- Founded
- POAI 2002
- ADTX 2017
- Country
- POAI United States
- ADTX United States
- Employees
- POAI N/A
- ADTX N/A
- Industry
- POAI Industrial Specialties
- ADTX Biotechnology: Pharmaceutical Preparations
- Sector
- POAI Health Care
- ADTX Health Care
- Exchange
- POAI Nasdaq
- ADTX Nasdaq
- Market Cap
- POAI 4.9M
- ADTX 5.3M
- IPO Year
- POAI N/A
- ADTX 2020
- Fundamental
- Price
- POAI $1.21
- ADTX $0.13
- Analyst Decision
- POAI Hold
- ADTX
- Analyst Count
- POAI 1
- ADTX 0
- Target Price
- POAI N/A
- ADTX N/A
- AVG Volume (30 Days)
- POAI 3.4M
- ADTX 39.3M
- Earning Date
- POAI 11-12-2024
- ADTX 11-18-2024
- Dividend Yield
- POAI N/A
- ADTX N/A
- EPS Growth
- POAI N/A
- ADTX N/A
- EPS
- POAI N/A
- ADTX N/A
- Revenue
- POAI $1,484,223.00
- ADTX $212,107.00
- Revenue This Year
- POAI N/A
- ADTX $95.61
- Revenue Next Year
- POAI $569.48
- ADTX $1,584.79
- P/E Ratio
- POAI N/A
- ADTX N/A
- Revenue Growth
- POAI N/A
- ADTX N/A
- 52 Week Low
- POAI $0.55
- ADTX $0.12
- 52 Week High
- POAI $3.76
- ADTX $218.00
- Technical
- Relative Strength Index (RSI)
- POAI 54.24
- ADTX 18.05
- Support Level
- POAI $1.16
- ADTX $0.12
- Resistance Level
- POAI $1.42
- ADTX $0.21
- Average True Range (ATR)
- POAI 0.36
- ADTX 0.03
- MACD
- POAI -0.00
- ADTX 0.03
- Stochastic Oscillator
- POAI 19.21
- ADTX 9.91
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.